PD1-T cells

BIOLOGICAL2 trials

Sponsors

Tianjin Medical University Cancer Institute and Hospital

Conditions

Colorectal CancerIIIB/IIIC/IV Lung Cancer

Phase 3

Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Advanced Lung Cancer

Tianjin Medical University Cancer Institute and HospitalIIIB/IIIC/IV Lung Cancer

Start: 2019-06-01End: 2022-06-01Target: 146Updated: 2019-06-14

Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal Cancer

Tianjin Medical University Cancer Institute and HospitalColorectal Cancer

Start: 2019-06-01End: 2023-08-01Target: 198Updated: 2023-08-01

Related Papers

Adoptive cellular immunotherapy combined with chemotherapy versus chemotherapy alone in Chinese patients with metastatic colorectal cancer: a cost-effectiveness analysis to inform drug pricing

Frontiers in Oncology2025-06-091 citations

XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial.

2024-04-0321 citations